🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Turn Therapeutics Inc. (TTRX)
NASDAQ: TTRX · Real-Time Price · USD
8.89
+0.34 (3.98%)
Nov 18, 2026, 4:00 PM EST - Market closed

Turn Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Net Income
-12.77-3.19-1.77-2.29-4.29
Depreciation & Amortization
0.060.050.050.040.05
Stock-Based Compensation
1.670.670.350.641.88
Other Operating Activities
3.53-2.460.0100.05
Change in Accounts Payable
0.152.260.20.21-0.3
Change in Unearned Revenue
---0.021.42
Change in Other Net Operating Assets
0.080.11-0.20-0.01
Operating Cash Flow
-5.28-2.56-1.36-1.38-1.21
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Sale (Purchase) of Intangibles
-0.07-0.15-0.1-0.04-0.02
Investing Cash Flow
-0.07-0.15-0.1-0.04-0.02

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Issuance of Common Stock
5.896.921.150.50.35
Financing Cash Flow
12.616.921.150.50.35

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Net Cash Flow
7.264.2-0.31-0.92-0.87

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Levered Free Cash Flow
-3.621.74-0.82-2.01-
Unlevered Free Cash Flow
-3.431.74-0.82-2.01-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Change in Working Capital
0.232.37-00.231.1
SEC Filings: 10-K · 10-Q